Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study

Background. The use of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) carries a risk of renal function deterioration in cirrhotic patients with ascites. However, whether the long-term use of ACEis/ARBs is safe in cirrhotic patients without ascites remains u...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei-Fan Hsu, Shi-Hang Yu, Jaw-Town Lin, Jaw-Ching Wu, Ming-Chih Hou, Yi-Hsiang Huang, Chun-Ying Wu, Cheng-Yuan Peng
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/1743290
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items